Navigation Links
Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
Date:7/16/2008

) R (p<0.001). Type 2 patients (n=173) receiving VIAject(TM) showed a weight reduction (-0.5 +/- 4.7 kg) compared to baseline, while a weight gain (0.8 +/- 6.2 kg) was seen in the patients (n=180) receiving Humulin(R) R (p<0.05), for a net difference of 1.3 kg.

The interim results demonstrated statistically significant daily meal-time (prandial) dose reductions in patients with Type 1 and Type 2 diabetes using VIAject(TM) compared to Humulin(R) R in the first six weeks of the study. With comparable glycemic control targets between treatment groups, Type 1 patients (n=106) receiving VIAject(TM) showed a 34 percent reduction in daily prandial dose (10 units; p<0.001) compared to baseline, while control patients receiving Humulin(R) R showed a non-significant 7 percent reduction (2.4 units). Type 2 patients receiving VIAject(TM) showed a 36 percent reduction (16 units; p<0.001), while control patients receiving Humulin(R) R showed an increase of 15 percent (6 units; p<0.01), for a net difference of 51 percent.

The interim results demonstrated statistically significant reductions in mild and moderate hypoglycemic events in patients with Type 1 and Type 2 diabetes using VIAject(TM) compared to Humulin(R) R. Type 1 patients recorded 8,111 mild and moderate hypoglycemic events, with a significantly lower number of incidents in the VIAject(TM) group (3,691; p<0.001) than in the Humulin(R) R group (4,420). Type 2 patients recorded 2,438 mild and moderate hypoglycemic events with a significantly lower number of incidents in the VIAject(TM) group (844 events) than in the Humulin(R) R group (1,594 events; p<0.001).

Biodel noted that the final data from these trials may differ from those suggested by the preliminary interim analysis. Furthermore the primary efficacy endpoint for the studies, change in HbA1c, has not been analyzed. Both HbA1c and incidences of severe hypoglycemic events will be analyzed and reported after the clinical trial database for the s
'/>"/>

SOURCE Biodel Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Biodel Inc. Completes Enrollment of Two Pivotal Phase III Clinical Trials of VIAject(TM) and Plans Manufacturing Facility for VIAject(TM)
2. Biodel Inc. Expands Ongoing Phase III VIAject(TM) Clinical Trials Into Europe
3. PTC Therapeutics Announces $25 Million Award From Cystic Fibrosis Foundation Therapeutics for Development of PTC124
4. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
5. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
6. Echo Therapeutics Announces Publication of Positive Clinical Data for its Symphony Transdermal Continuous Glucose Monitoring System in Journal of Diabetes Science and Technology
7. Nile Therapeutics Announces Dosing in Phase IIa Study of CD-NP in Heart Failure Patients
8. Insmed Announces First Human Bioequivalence Data for a Follow-on Biologic by a U.S. Company
9. BioCryst Announces Initiation of Phase II Study of Intramuscular Peramivir for the Treatment of Seasonal Influenza
10. Sosei Announces Completion of Phase III Trial for NorLevo(R)
11. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... SAN ANTONIO , April 28, 2015 /PRNewswire/ ... that the U.S. Patent and Trademark Office has ... GenSpera,s intellectual property portfolio claiming numerous compositions for ... Prostate Specific Antigen (PSA).  GenSpera ... specific peptides with a powerful cytotoxin isolated from ...
(Date:4/28/2015)... 2015 /CNW/ - The group representing the living victims of ... a two-hour meeting with Health Canada officials in a ... Canada announced a $180 million support package for Thalidomide ... after the Health Canada announcement and five months after ... victims, the group representing Canada,s ...
(Date:4/28/2015)... April 28, 2015 Anteo Technologies is ... new tools developed with their patented Mix&Go™ Activation ... methods, helping to improve medical devices and in-vitro ... Increasingly complex multifactorial diagnosis of cancer and ... It is restricted to measure only a ...
Breaking Medicine Technology:GenSpera Granted New Patent for Prodrugs Activated by Prostate Specific Antigen 2Thalidomide Victims Gravely Concerned by Health Canada's Silence 2Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 2Faster Detection of Disease: Anteo is Transforming The Way Scientists Work with Luminex(R) xMAP(R) 3
... Md., May 23, 2011 The healthcare and computing ... the healthcare industry has been adopting new technologies allowing ... medical devices strive to meet these requirements of the ... (near field frequency) chips in medical devices for communication ...
... Olympus Biotech, an Olympus Corporation company, today ... of president of Olympus Biotech Corporation. In his new ... business and focus on expanding opportunities for the emerging ... member of the Olympus Biotech Board of Directors. ...
Cached Medicine Technology:Your Wireless Healthcare Provided By PulseOximetersPlus 2Olympus Biotech Names Oliver Burckhardt to President North America 2
(Date:4/28/2015)... New York (PRWEB) April 28, 2015 ... http://www.xareltolawsuit2015.com/ ) are moving forward nationwide, as courts ... convene conferences next month. According to court documents ... of Louisiana, the next status conference in the ... 13th at 9:00 a.m. C.S.T. (In Re: ...
(Date:4/28/2015)... San Fancisco, California (PRWEB) April 28, 2015 ... and Clear Skin Concierge have developed a new, ... and treatment for acne sufferers using their specialized ... allows residents anywhere in the state of California ... without the need to travel to a physical ...
(Date:4/28/2015)... Georgia State University’s School of Public Health ... partner with the school on efforts to improve policies ... produces more tobacco and has more smokers than any ... Control Partnership-Tobacco Free Cities, will focus on a group ... tobacco control efforts and where public health organizations are ...
(Date:4/28/2015)... MSA Executive Search , an ... today that it has been retained to lead a ... for The Queen's Health Systems (QHS) located ... President & CEO Arthur A. Ushijima, the Executive Vice ... for the Queen’s Medical Center Punchbowl and West O’ahu ...
(Date:4/28/2015)... Georgia Partnership for TeleHealth (GPT), ... in communities throughout Georgia, announces that four members of ... the American Telemedicine Association ’s ATA 2015 conference, ... CA. , GPT’s roster of conference speakers includes ... Loren Nix, Liaison; and board member Dr. Jean Summer. ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 2Health News:Xarelto Lawsuits Move Forward Nationwide, with Scheduling of May Conferences in Federal, State Litigations 3Health News:New Online Acne Treatment Service for California 2Health News:Georgia State Names Partner Cities For Tobacco Control Project 2Health News:The Queen’s Health Systems Retains MSA Executive Search to Recruit Executive Vice President & Chief Operating Officer 2Health News:Georgia Partnership for TeleHealth Team Selected to Present at ATA 2015 2
... risk of recurrence in those who delay it , THURSDAY, ... breast cancer surgery, the question of whether or not to ... research that suggests that the longer women wait, the greater ... the March 3 online edition of BMJ , are ...
... ... Susan G. Komen Race for the Cure® events across the country. , ... Collegedale, TN (Vocus) March 4, 2010 -- Sunbelt ® ... events across the country. , , , , ,“The Sunbelt employees who volunteered and participated in ...
... , ... ... ... ...
... ... most wanted gifts for UK mums this Mother,s Day , ... London, UK (PRWEB) March 4, 2010 -- Voucher codes website Savoo.co.uk ... Boots voucher codes travel and clothing are the top three most desired gifts by ...
... ... ... ... ...
... ... the creation of an online education series for treatment professionals. , ... Carlsbad, CA (PRWEB) ... has announced the creation of an online education series for treatment professionals., , ...
Cached Medicine News:Health News:Sunbelt Announces Renewed Commitment to Breast Cancer Awareness 2Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 2Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 3Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 4Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 5Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 6Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 7Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 8Health News:Watson Announces Agreement to Acquire U.S. Rights to Columbia Laboratories' CRINONE(R) Progesterone Gel Product Line 9Health News:Voucher Site Savoo.co.uk Reveals What Mum's Really Want This Mother's Day 2Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 2Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 3Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 4Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 5Health News:State-of-the Art in Alzheimer's Research Featured at 25th Conference of Alzheimer's Disease International 6Health News:Montecatini Eating Disorders Program Announces 'Log In & Learn' Webinar Series for Treatment Professionals 2Health News:Montecatini Eating Disorders Program Announces 'Log In & Learn' Webinar Series for Treatment Professionals 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: